103 related articles for article (PubMed ID: 12458319)
1. [Optimization of asthma control with fluticasone/salmeterol (seretide) combination: new clinical data].
Braunstein G
Rev Pneumol Clin; 2002 Jun; 58(3 Pt 2):1S12-5; discussion 1S16. PubMed ID: 12458319
[No Abstract] [Full Text] [Related]
2. Body mass index and response to asthma therapy: fluticasone propionate/salmeterol versus montelukast.
Camargo CA; Boulet LP; Sutherland ER; Busse WW; Yancey SW; Emmett AH; Ortega HG; Ferro TJ
J Asthma; 2010 Feb; 47(1):76-82. PubMed ID: 20100025
[TBL] [Abstract][Full Text] [Related]
3. Salmeterol/fluticasone propionate combination product in asthma. An evaluation of its cost effectiveness vs fluticasone propionate.
Pharmacoeconomics; 1999; 16 Suppl 2():i-viii, 1-34. PubMed ID: 10724799
[No Abstract] [Full Text] [Related]
4. Effect of salmeterol/fluticasone propionate combination on airway hyper-responsiveness in patients with well-controlled asthma.
Chanez P; Stallaert R; Reznikova E; Bloemen P; Adamek L; Joos G
Respir Med; 2010 Aug; 104(8):1101-9. PubMed ID: 20452196
[TBL] [Abstract][Full Text] [Related]
5. Influence of obesity on response to fluticasone with or without salmeterol in moderate asthma.
Boulet LP; Franssen E
Respir Med; 2007 Nov; 101(11):2240-7. PubMed ID: 17686624
[TBL] [Abstract][Full Text] [Related]
6. EXCEL: A randomised trial comparing salmeterol/fluticasone propionate and formoterol/budesonide combinations in adults with persistent asthma.
Dahl R; Chuchalin A; Gor D; Yoxall S; Sharma R
Respir Med; 2006 Jul; 100(7):1152-62. PubMed ID: 16675212
[TBL] [Abstract][Full Text] [Related]
7. Lower inhaled steroid requirement with a fluticasone/salmeterol combination in family practice patients with asthma or COPD.
Schermer TR; Albers JM; Verblackt HW; Costongs RJ; Westers P
Fam Pract; 2007 Apr; 24(2):181-8. PubMed ID: 17251178
[TBL] [Abstract][Full Text] [Related]
8. Retrospective claims study of fluticasone propionate/salmeterol fixed-dose combination use as initial asthma controller therapy in children despite guideline recommendations.
Friedman HS; Eid NS; Crespi S; Wilcox TK; Reardon G
Clin Ther; 2009 May; 31(5):1056-63. PubMed ID: 19539106
[TBL] [Abstract][Full Text] [Related]
9. Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: the Pediatric Asthma Controller Trial.
Sorkness CA; Lemanske RF; Mauger DT; Boehmer SJ; Chinchilli VM; Martinez FD; Strunk RC; Szefler SJ; Zeiger RS; Bacharier LB; Bloomberg GR; Covar RA; Guilbert TW; Heldt G; Larsen G; Mellon MH; Morgan WJ; Moss MH; Spahn JD; Taussig LM;
J Allergy Clin Immunol; 2007 Jan; 119(1):64-72. PubMed ID: 17140647
[TBL] [Abstract][Full Text] [Related]
10. [Budesonide/formoterol maintenance and reliever therapy. A new treatment approach for adult patients with asthma].
Korn S; Vogelmeier C; Buhl R
Med Klin (Munich); 2008 May; 103(5):299-310. PubMed ID: 18484216
[TBL] [Abstract][Full Text] [Related]
11. A combination of fluticasone and salmeterol for asthma.
Med Lett Drugs Ther; 2001 Apr; 43(1102):31-3. PubMed ID: 11309534
[No Abstract] [Full Text] [Related]
12. Fluticasone/salmeterol: labeling change.
Prescrire Int; 2008 Dec; 17(98):229. PubMed ID: 19418648
[TBL] [Abstract][Full Text] [Related]
13. A proof of concept study to evaluate stepping down the dose of fluticasone in combination with salmeterol and tiotropium in severe persistent asthma.
Fardon T; Haggart K; Lee DK; Lipworth BJ
Respir Med; 2007 Jun; 101(6):1218-28. PubMed ID: 17178217
[TBL] [Abstract][Full Text] [Related]
14. Patient-reported outcomes among omalizumab and salmeterol/fluticasone combination therapy patients.
Miller DP; Tom G; Rasouliyan L; Chipps B
J Asthma; 2009 Mar; 46(2):179-85. PubMed ID: 19253127
[TBL] [Abstract][Full Text] [Related]
15. Combination therapy with the single inhaler salmeterol/fluticasone propionate versus increased doses of inhaled corticosteroids in patients with asthma.
Li HT; Zhang TT; Zhou H; Qu XJ; Wu WM; Huang J
Respiration; 2007; 74(1):33-43. PubMed ID: 17008769
[TBL] [Abstract][Full Text] [Related]
16. Changes in lung function and health status in patients with COPD treated with tiotropium or salmeterol plus fluticasone.
Kurashima K; Hara K; Yoneda K; Kanauchi T; Kagiyama N; Tokunaga D; Takayanagi N; Ubukata M; Sugita Y
Respirology; 2009 Mar; 14(2):239-44. PubMed ID: 19210650
[TBL] [Abstract][Full Text] [Related]
17. Initiation of maintenance therapy with salmeterol/fluticasone propionate combination therapy in moderate asthma: a comparison with fluticasone propionate.
Rojas RA; Paluga I; Goldfrad CH; Duggan MT; Barnes N
J Asthma; 2007; 44(6):437-41. PubMed ID: 17654129
[TBL] [Abstract][Full Text] [Related]
18. [A fixed combination of fluticasone and salmeterol permits better control of asthma than a beclomethasone dipropionate and montelukast combination].
Grosclaude M; Cerruti JL; Delannay B; Hérent M; Spilthooren F; Desfougères JL
Eur Ann Allergy Clin Immunol; 2003 Nov; 35(9):356-62. PubMed ID: 14716965
[TBL] [Abstract][Full Text] [Related]
19. Effect of fluticasone propionate/salmeterol (250/50 microg) or salmeterol (50 microg) on COPD exacerbations.
Ferguson GT; Anzueto A; Fei R; Emmett A; Knobil K; Kalberg C
Respir Med; 2008 Aug; 102(8):1099-108. PubMed ID: 18614347
[TBL] [Abstract][Full Text] [Related]
20. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
